Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJ.A. Witjes, Lambertus A.L.M. Kiemeney, Leon L. Wheeless, Herbert Barton Grossman
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
1973
Unresolved referenced work
1975
Bladder carcinoma and a TNM system of classification
10.1016/s0022-5347(17)58544-4 · 1977
Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ
10.1016/s0022-5347(17)58916-8 · 1976
The lower urinary tract
1989
Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer
10.1016/s0022-5347(17)35397-1 · 1993
Long term follow-up of an EORTC randomized prospective trial comparing intravesical BCG-RIVM and mitomycin C in superficial bladder cancer
10.1016/s0090-4295(98)00212-x · 1998
A randomized study of intrasvesical Mitomycin-C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder
10.1016/s0022-5347(01)67606-7 · 1995
Prognostic factors in superficial bladder cancer. A review
10.1159/000474811 · 1992
Progression of stage T1 bladder tumors after intravesical Bacillus Calmette-Guerin
Confidence 0%
10.1016/s0022-5347(17)38242-3 · 1991
Longitudinal study of patients with bladder cancer
1982
Superficial bladder cancer
10.1016/s0022-5347(17)51695-x · 1983
Treated history of noninvasive grade 1 transitional cell carcinoma
10.1016/s0022-5347(17)36924-0 · 1992
Prognostic factors in pTa-pT1 superficial bladder tumors treated with intravesical instillations
10.1111/j.1464-410x.1994.tb07604.x · 1994
Analysis of bladder carcinoma by subsite
10.1002/1097-0142(19901001)66:7<1630::aid-cncr2820660730>3.0.co;2-7 · 1990
Analysis of bladder tumor recurrence in 178 patients
10.1016/0090-4295(80)90066-7 · 1980
Prostatic involvement by transitional cell carcinoma
10.1016/s0022-5347(17)58039-8 · 1977
The application of a prognostic factor analysis for Ta, T1 bladder cancer in routine urological practice
10.1111/j.1464-410x.1995.tb07417.x · 1995
Prognostic parameters in superficial bladder cancer
10.1016/s0022-5347(17)53725-8 · 1982
Prognostic factors in superficial bladder tumors. A study of the EORTC GU Group
10.1016/s0022-5347(17)52330-7 · 1983
Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer
10.1016/s0022-5347(17)38731-1 · 1989
Rationalization of follow-up in patients with non-invasive bladder tumors. A preliminary report
10.1111/j.1464-410x.1991.tb15099.x · 1991
Superficial bladder tumors (stage pTa, grades 1 and 2)
10.1016/s0022-5347(17)45923-4 · 1986
The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years
10.1016/s0022-5347(01)67321-x · 1995
Unresolved referenced work
1987
Unresolved referenced work
1975
Analysis of the performance of pathologists in the grading of bladder tumors
10.1016/s0046-8177(83)80242-1 · 1983
Benign and low grade papillary lesions of the urinary bladder
1989
Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder
10.1111/j.1464-410x.1988.tb04361.x · 1988
Cancer registry problems in classifying invasive bladder cancer
10.1093/jnci/83.6.429 · 1991
The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial
10.1111/j.1464-410x.1994.tb07487.x · 1994
The significance of bladder quadrant biopsies in patients with primary superficial bladder cancer
10.1159/000471541 · 1989
Should random urothelium biopsies be taken from patients with primary superficial bladder cancer? A decision analysis
10.1111/j.1464-410x.1994.tb07486.x · 1994
Superficial bladder cancer
10.1111/j.1464-410x.1995.tb07310.x · 1995
Bladder cancer, factors affecting survival
10.1016/s0022-5347(17)50952-0 · 1983
Multivariate evaluation of prognostic determinants in bladder cancer patients
10.1159/000281996 · 1987
Volume corrected mitotic index (M/V index) in human bladder cancer
10.3109/00365599009180358 · 1990
Factors affecting survival in primary superficial bladder cancer
10.1159/000464017 · 1990
The value of histologic grading and staging, random biopsies, tumor and bladder mucosa blood group antigens, in predicting progression of superficial bladder cancer
10.1159/000463506 · 1984
Multivariate analysis of progression in superficial bladder cancer
10.1111/j.1464-410x.1993.tb15944.x · 1993
Consensus review of clinical utility of DNA cytometry in bladder cancer
10.1002/cyto.990140504 · doi-reference
Intratumoral heterogeneity in DNA ploidy of bladder carcinomas
10.1159/000227042 · doi-reference
Image analysis DNA cytometry of bladder cancer
10.1007/978-3-642-84583-3_15 · doi-reference
Prognostic significance of mucosal aneuploidy in stage Ta/T1 grade 3 carcinoma of the bladder
10.1016/s0022-5347(17)36926-4 · doi-reference
Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma
10.1016/s0022-5347(17)38563-4 · doi-reference
Image cytometric DNA analysis in transitional cell carcinoma of the bladder
10.1002/1097-0142(19930701)72:1<182::aid-cncr2820720133>3.0.co;2-w · doi-reference
Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional cell bladder cancer
10.1002/ijc.2910530109 · doi-reference
Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder
10.1016/s0022-5347(01)64322-2 · doi-reference
Flow cytometric DNA/cytokeratin analysis of bladder lavage
10.1159/000282686 · doi-reference
Evaluation of DNA flow cytometry as a screening test for bladder cancer
10.1002/jcb.240501318 · doi-reference
Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry
10.1159/000474883 · doi-reference
Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry
10.1016/s0022-5347(17)36196-7 · doi-reference
The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumors
10.1111/j.1464-410x.1982.tb13536.x · doi-reference
Progression and survival in transitional cell bladder cancer
10.1016/0277-5379(91)90138-4 · doi-reference
P53 and ploidy assessed by flow cytometry in bladder washings
10.1111/j.1464-410x.1995.tb07781.x · doi-reference
Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei
10.1002/cyto.990170407 · doi-reference
Quanticyt
10.1016/s0090-4295(96)00210-5 · doi-reference
Karyometry in recurrent superficial transitional cell tumors of the bladder
10.1007/bf00922753 · doi-reference
Monoclonal antibodies in bladder cancer cytology
10.1007/bf00184037 · doi-reference
The value of urinary cytology, serum and urinary carcinoembryogenic antigen, rheumatoid factors and urinary immunoglobulin concentration as tumor markers or prognostic factors in predicting progression of superficial bladder cancer
10.1159/000474121 · doi-reference
Microstaging of pT1 transitional cell carcinoma of the bladder
10.1016/s0090-4295(98)00374-4 · doi-reference
The importance of the depth of invasion in stage T1 bladder carcinoma
10.1016/s0022-5347(01)65044-4 · doi-reference
Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer
10.1016/s0090-4295(95)96490-8 · doi-reference
Significance of invasion to the muscularis mucosa on the progression of superficial bladder cancer
10.1016/0090-4295(94)90134-1 · doi-reference
The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder
10.1002/1097-0142(19900801)66:3<543::aid-cncr2820660323>3.0.co;2-r · doi-reference
Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder
10.1111/j.1464-410x.1989.tb05521.x · doi-reference